- Home
- ISTR vs RCKT Comparison
ISTR vs RCKT Comparison
Compare ISTR & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ISTR | RCKT |
|---|---|---|
| Founded | 2006 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 394.5M | 394.2M |
| IPO Year | 2014 | 2014 |
Fundamental Metrics
Financial Performance| Metric | ISTR | RCKT |
|---|---|---|
| Price | $30.95 | $3.47 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 14 |
| Target Price | ★ $31.50 | $29.73 |
| AVG Volume (30 Days) | 153.9K | ★ 1.4M |
| Earning Date | 04-20-2026 | 05-04-2026 |
| Dividend Yield | ★ 1.59% | N/A |
| EPS Growth | 4.41 | ★ 26.37 |
| EPS | ★ 1.38 | 0.66 |
| Revenue | N/A | N/A |
| Revenue This Year | $66.56 | N/A |
| Revenue Next Year | $5.18 | $64.28 |
| P/E Ratio | $22.35 | ★ $5.06 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $21.43 | $2.53 |
| 52 Week High | $31.27 | $5.45 |
Technical Indicators
Market Signals| Indicator | ISTR | RCKT |
|---|---|---|
| Relative Strength Index (RSI) | 62.01 | 50.75 |
| Support Level | $28.75 | $3.32 |
| Resistance Level | N/A | $3.63 |
| Average True Range (ATR) | 0.54 | 0.19 |
| MACD | 0.06 | 0.01 |
| Stochastic Oscillator | 76.14 | 61.04 |
Price Performance
Historical ComparisonAbout ISTR Investar Holding Corporation
Investar Holding Corp is a U.S.-based financial holding company. Through its subsidiaries, it offers a variety of commercial and retail lending products throughout its market areas, including business loans to small to medium-sized businesses, as well as loans to individuals. It has business operations spread across the United States and serves its customers through several service branches. The bank also offers cashier's checks, direct deposit of payroll and Social Security checks, night depository, bank-by-mail, automated teller machines with deposit automation, and debit cards.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.